Interact to see
Advertisement
Advertisement
CURE vs SPXL
CURE vs SPXL Comparison Chart in %
Loading...
Show more...
Show more...
View a ticker or compare two or three
VS
VS
CURE vs. SPXL commentary
Jul 03, 2025
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CURE is a StrongBuy and SPXL is a Buy.
SUMMARIES
FUNDAMENTALS
Fundamentals
SPXL has more net assets: 5.57B vs. CURE (140M). SPXL has a higher annual dividend yield than CURE: SPXL (4.701) vs CURE (-12.980). CURE was incepted earlier than SPXL: CURE (14 years) vs SPXL (17 years). SPXL (0.87) has a lower expense ratio than CURE (0.93). SPXL has a higher turnover CURE (23.00) vs CURE (23.00).
| CURE | SPXL | CURE / SPXL | |
| Gain YTD | -12.980 | 4.701 | -276% |
| Net Assets | 140M | 5.57B | 3% |
| Total Expense Ratio | 0.93 | 0.87 | 107% |
| Turnover | 23.00 | 29.00 | 79% |
| Yield | 1.40 | 0.91 | 153% |
| Fund Existence | 14 years | 17 years | - |
TECHNICAL ANALYSIS
Technical Analysis
| CURE | SPXL | |
|---|---|---|
| RSI ODDS (%) | N/A | 2 days ago 90% |
| Stochastic ODDS (%) | 2 days ago 89% | 2 days ago 85% |
| Momentum ODDS (%) | 2 days ago 85% | 2 days ago 90% |
| MACD ODDS (%) | N/A | 2 days ago 90% |
| TrendWeek ODDS (%) | 2 days ago 90% | 2 days ago 90% |
| TrendMonth ODDS (%) | 2 days ago 90% | 2 days ago 90% |
| Advances ODDS (%) | 3 days ago 90% | 4 days ago 90% |
| Declines ODDS (%) | 14 days ago 90% | 14 days ago 89% |
| BollingerBands ODDS (%) | 2 days ago 90% | 2 days ago 90% |
| Aroon ODDS (%) | 2 days ago 90% | 2 days ago 90% |
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
Show more...
Show more...